ExxonMobil Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
ExxonMobil Investment Management's BMY Position: Q1 2018 in Review
ExxonMobil Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 4% in Q1 2018, selling an estimated $663K and leaving 249,932 shares worth $15.8M. The position accounts for 0.46% of the portfolio, ranked #50.
ExxonMobil Investment Management first reported a position in BMY in Q2 2013 and has held it in 20 quarters since. The position peaked at $31.8M in Q2 2016. 1,747 funds tracked by Wall St. Rank hold BMY as of Q1 2018.
- ExxonMobil Investment Management held 249,932 shares of Bristol-Myers Squibb worth $15.8M as of Q1 2018.
- ExxonMobil Investment Management sold 10,311 Bristol-Myers Squibb shares in Q1 2018, an estimated $663K.
- Bristol-Myers Squibb made up 0.46% of ExxonMobil Investment Management's portfolio in Q1 2018, its #50 holding.
- ExxonMobil Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 20 quarters since.
- ExxonMobil Investment Management's Bristol-Myers Squibb position peaked at $31.8M in Q2 2016.
- 1,747 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2018.
Based on ExxonMobil Investment Management's 13F filing for Q1 2018, filed 12 Apr 2018.